• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sox2拮抗Hippo信号通路以维持癌细胞的干性。

Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.

作者信息

Basu-Roy Upal, Bayin N Sumru, Rattanakorn Kirk, Han Eugenia, Placantonakis Dimitris G, Mansukhani Alka, Basilico Claudio

机构信息

Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA.

Department of Neurosurgery, New York University School of Medicine, New York, New York 10016, USA.

出版信息

Nat Commun. 2015 Apr 2;6:6411. doi: 10.1038/ncomms7411.

DOI:10.1038/ncomms7411
PMID:25832504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4429898/
Abstract

The repressive Hippo pathway has a profound tumour suppressive role in cancer by restraining the growth-promoting function of the transcriptional coactivator, YAP. We previously showed that the stem cell transcription factor Sox2 maintains cancer stem cells (CSCs) in osteosarcomas. We now report that in these tumours, Sox2 antagonizes the Hippo pathway by direct repression of two Hippo activators, Nf2 (Merlin) and WWC1 (Kibra), leading to exaggerated YAP function. Repression of Nf2, WWC1 and high YAP expression marks the CSC fraction of the tumor population, while the more differentiated fraction has high Nf2, high WWC1 and reduced YAP expression. YAP depletion sharply reduces CSCs and tumorigenicity of osteosarcomas. Thus, Sox2 interferes with the tumour-suppressive Hippo pathway to maintain CSCs in osteosarcomas. This Sox2-Hippo axis is conserved in other Sox2-dependent cancers such as glioblastomas. Disruption of YAP transcriptional activity could be a therapeutic strategy for Sox2-dependent tumours.

摘要

具有抑制作用的Hippo信号通路通过抑制转录共激活因子YAP的促生长功能,在癌症中发挥着重要的肿瘤抑制作用。我们之前的研究表明,干细胞转录因子Sox2维持骨肉瘤中的癌症干细胞(CSC)。我们现在报告,在这些肿瘤中,Sox2通过直接抑制两种Hippo激活因子Nf2(Merlin)和WWC1(Kibra)来拮抗Hippo信号通路,从而导致YAP功能过度增强。Nf2、WWC1的抑制以及YAP的高表达标志着肿瘤群体中的CSC部分,而分化程度较高的部分则具有高Nf2、高WWC1和降低的YAP表达。YAP的缺失会显著减少骨肉瘤中的CSC和致瘤性。因此,Sox2干扰具有肿瘤抑制作用的Hippo信号通路,以维持骨肉瘤中的CSC。这种Sox2-Hippo轴在其他依赖Sox2的癌症如胶质母细胞瘤中是保守的。破坏YAP的转录活性可能是治疗依赖Sox2的肿瘤的一种策略。

相似文献

1
Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.Sox2拮抗Hippo信号通路以维持癌细胞的干性。
Nat Commun. 2015 Apr 2;6:6411. doi: 10.1038/ncomms7411.
2
WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.WWC1 和 NF2 通过调节 LATS 在小鼠中抑制 YAP/TAZ 活性从而预防肝内胆管细胞癌的发生。
Mol Cells. 2020 May 31;43(5):491-499. doi: 10.14348/molcells.2020.0093.
3
Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.他汀类药物可抑制失活Hippo信号通路的恶性间皮瘤细胞,并阻断YAP/CD44生长刺激轴。
Cancer Lett. 2017 Jan 28;385:215-224. doi: 10.1016/j.canlet.2016.10.020. Epub 2016 Oct 20.
4
Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.miR-130b的上调通过使Hippo信号通路失活增强胶质母细胞瘤中的干细胞样表型。
Biochem Biophys Res Commun. 2015 Sep 18;465(2):194-9. doi: 10.1016/j.bbrc.2015.07.149. Epub 2015 Aug 1.
5
KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.KIBRA 通过 MST 非依赖性机制调节哺乳动物 Hippo 信号通路的功能。
Oncogene. 2013 Apr 4;32(14):1821-30. doi: 10.1038/onc.2012.196. Epub 2012 May 21.
6
The Hippo pathway member Nf2 is required for inner cell mass specification.Hippo 通路成员 NF2 对于内细胞团的特化是必需的。
Curr Biol. 2013 Jul 8;23(13):1195-201. doi: 10.1016/j.cub.2013.05.044. Epub 2013 Jun 20.
7
Myeloid Zinc Finger 1 and GA Binding Protein Co-Operate with Sox2 in Regulating the Expression of Yes-Associated Protein 1 in Cancer Cells.髓样锌指蛋白 1 和 GA 结合蛋白在调节癌细胞中 Yes 相关蛋白 1 的表达中与 Sox2 协同作用。
Stem Cells. 2017 Dec;35(12):2340-2350. doi: 10.1002/stem.2705. Epub 2017 Sep 29.
8
The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.Hippo 通路调节剂 KIBRA 通过抑制 YAP 信号通路和破坏肌动蛋白细胞骨架动力学促进足细胞损伤。
J Biol Chem. 2017 Dec 22;292(51):21137-21148. doi: 10.1074/jbc.M117.819029. Epub 2017 Oct 5.
9
Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.河马/Yes相关蛋白信号通路参与骨肉瘤化疗耐药。
Chin J Cancer. 2016 May 20;35:47. doi: 10.1186/s40880-016-0109-z.
10
SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.SOX2 拮抗 WWCl 以驱动食管鳞状细胞癌中的 YAP1 激活。
Cancer Med. 2019 Nov;8(16):7055-7064. doi: 10.1002/cam4.2569. Epub 2019 Sep 27.

引用本文的文献

1
Signaling pathways as the pivotal regulators of cisplatin resistance in tumor cells through SOX2 upregulation.信号通路作为通过上调SOX2在肿瘤细胞中顺铂耐药的关键调节因子。
Med Oncol. 2025 Aug 22;42(10):437. doi: 10.1007/s12032-025-03004-9.
2
PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3.依赖PDK1的代谢重编程通过ATF3调节骨肉瘤干细胞的干性和致瘤性。
Cell Death Dis. 2025 Jul 29;16(1):574. doi: 10.1038/s41419-025-07903-7.
3
The Hippo pathway in bone and cartilage: implications for development and disease.

本文引用的文献

1
SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma.SOX2是皮肤鳞状细胞癌中肿瘤起始潜能的癌症特异性调节因子。
Nat Commun. 2014 Jul 31;5:4511. doi: 10.1038/ncomms5511.
2
Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.梅林/NF2 缺失驱动的肿瘤发生与 CRL4(DCAF1)介导的 hippo 通路激酶 Lats1 和 2 在核内的抑制有关。
Cancer Cell. 2014 Jul 14;26(1):48-60. doi: 10.1016/j.ccr.2014.05.001.
3
KRAS and YAP1 converge to regulate EMT and tumor survival.
骨骼与软骨中的河马信号通路:对发育和疾病的影响
PeerJ. 2025 Apr 22;13:e19334. doi: 10.7717/peerj.19334. eCollection 2025.
4
The Hippo pathway and p27 cooperate to suppress mitotic regeneration in the organ of Corti and the retina.河马通路和p27协同作用,抑制柯蒂氏器和视网膜中的有丝分裂再生。
Proc Natl Acad Sci U S A. 2025 Apr 8;122(14):e2411313122. doi: 10.1073/pnas.2411313122. Epub 2025 Apr 3.
5
Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression.雄激素剥夺治疗后VRK1水平升高通过上调YAP1表达促进前列腺癌进展。
J Cancer Res Clin Oncol. 2025 Mar 20;151(3):116. doi: 10.1007/s00432-025-06168-z.
6
Developmental-status-aware transcriptional decomposition establishes a cell state panorama of human cancers.发展阶段感知转录分解建立了人类癌症的细胞状态全景图。
Genome Med. 2024 Oct 28;16(1):124. doi: 10.1186/s13073-024-01393-6.
7
Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application.肝细胞癌中 DNA 甲基化的综合回顾和最新分析:从基础研究到临床应用。
Clin Transl Med. 2024 Nov;14(11):e70066. doi: 10.1002/ctm2.70066.
8
The Role of Deubiquitinating Enzymes in Primary Bone Cancer.去泛素化酶在原发性骨癌中的作用
Mol Biotechnol. 2024 Aug 23. doi: 10.1007/s12033-024-01254-y.
9
Cancer stem cells: advances in knowledge and implications for cancer therapy.癌症干细胞:知识进展及其对癌症治疗的影响。
Signal Transduct Target Ther. 2024 Jul 5;9(1):170. doi: 10.1038/s41392-024-01851-y.
10
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).针对 Hippo 通路以预防来自肺部的放射性耐药脑转移 (综述)。
Int J Oncol. 2024 Jul;65(1). doi: 10.3892/ijo.2024.5656. Epub 2024 May 24.
KRAS 和 YAP1 共同调控 EMT 和肿瘤存活。
Cell. 2014 Jul 3;158(1):171-84. doi: 10.1016/j.cell.2014.06.004. Epub 2014 Jun 19.
4
The Hippo signaling pathway in stem cell biology and cancer.干细胞生物学与癌症中的河马信号通路。
EMBO Rep. 2014 Jun;15(6):642-56. doi: 10.15252/embr.201438638. Epub 2014 May 12.
5
Molecular insights into NF2/Merlin tumor suppressor function.NF2/Merlin 肿瘤抑制因子功能的分子见解。
FEBS Lett. 2014 Aug 19;588(16):2743-52. doi: 10.1016/j.febslet.2014.04.001. Epub 2014 Apr 12.
6
Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma.Sox2 在高级少突胶质细胞瘤的小鼠模型中维持癌症干细胞。
Cancer Res. 2014 Mar 15;74(6):1833-44. doi: 10.1158/0008-5472.CAN-13-1942. Epub 2014 Mar 5.
7
Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation.在成骨分化过程中,经典Wnt信号通路通过蛋白磷酸酶1A(PP1A)激活转录共激活因子TAZ。
Cell Death Differ. 2014 Jun;21(6):854-63. doi: 10.1038/cdd.2014.8. Epub 2014 Feb 7.
8
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis.肿瘤增殖细胞和 Yap/Taz 活性促进肺肿瘤的进展和转移。
EMBO J. 2014 Mar 3;33(5):468-81. doi: 10.1002/embj.201386082. Epub 2014 Feb 4.
9
Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency.通过 Sox2 介导的 mTOR 抑制来短暂激活自噬,是重编程为多能性的重要早期步骤。
Cell Stem Cell. 2013 Nov 7;13(5):617-25. doi: 10.1016/j.stem.2013.10.005.
10
Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression. hedgehog 信号通路通过 Yap1 和 h19 的过表达诱导骨肉瘤的发生。
Oncogene. 2014 Oct 2;33(40):4857-66. doi: 10.1038/onc.2013.433. Epub 2013 Oct 21.